CN102617730B - 一种美沙酮人工抗原的制备方法 - Google Patents
一种美沙酮人工抗原的制备方法 Download PDFInfo
- Publication number
- CN102617730B CN102617730B CN2012101056039A CN201210105603A CN102617730B CN 102617730 B CN102617730 B CN 102617730B CN 2012101056039 A CN2012101056039 A CN 2012101056039A CN 201210105603 A CN201210105603 A CN 201210105603A CN 102617730 B CN102617730 B CN 102617730B
- Authority
- CN
- China
- Prior art keywords
- methadone
- preparation
- artificial antigen
- product
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 title claims abstract description 65
- 239000000427 antigen Substances 0.000 title claims abstract description 40
- 102000036639 antigens Human genes 0.000 title claims abstract description 40
- 108091007433 antigens Proteins 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 25
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 19
- 229960001797 methadone Drugs 0.000 claims description 57
- 239000000243 solution Substances 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 25
- 239000000047 product Substances 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 22
- 238000004809 thin layer chromatography Methods 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000013016 damping Methods 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000000502 dialysis Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 229910000071 diazene Inorganic materials 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000012265 solid product Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000006386 neutralization reaction Methods 0.000 claims description 2
- 229910001415 sodium ion Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 11
- 238000001514 detection method Methods 0.000 abstract description 10
- 238000003018 immunoassay Methods 0.000 abstract description 4
- 238000009833 condensation Methods 0.000 abstract description 3
- 230000005494 condensation Effects 0.000 abstract description 3
- 230000032050 esterification Effects 0.000 abstract description 3
- 238000005886 esterification reaction Methods 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 3
- 230000003647 oxidation Effects 0.000 abstract description 3
- 238000007254 oxidation reaction Methods 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- NEBPTMCRLHKPOB-UHFFFAOYSA-N 2,2-diphenylacetonitrile Chemical compound C=1C=CC=CC=1C(C#N)C1=CC=CC=C1 NEBPTMCRLHKPOB-UHFFFAOYSA-N 0.000 abstract 1
- 150000001718 carbodiimides Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000006722 reduction reaction Methods 0.000 abstract 1
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical compound O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000031700 light absorption Effects 0.000 description 14
- 230000000890 antigenic effect Effects 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 6
- 238000005303 weighing Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229960005181 morphine Drugs 0.000 description 3
- GYXWNSDLDXGMGU-UHFFFAOYSA-N 2-chloro-n,n-dimethylpropan-1-amine Chemical compound CC(Cl)CN(C)C GYXWNSDLDXGMGU-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000010408 sweeping Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- 206010027646 Miosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000003547 miosis Effects 0.000 description 1
- 239000002756 mu opiate receptor agonist Substances 0.000 description 1
- 229940126487 mu opioid receptor agonist Drugs 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Images
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101056039A CN102617730B (zh) | 2012-04-11 | 2012-04-11 | 一种美沙酮人工抗原的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101056039A CN102617730B (zh) | 2012-04-11 | 2012-04-11 | 一种美沙酮人工抗原的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102617730A CN102617730A (zh) | 2012-08-01 |
CN102617730B true CN102617730B (zh) | 2013-07-31 |
Family
ID=46557979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101056039A Active CN102617730B (zh) | 2012-04-11 | 2012-04-11 | 一种美沙酮人工抗原的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102617730B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103360271B (zh) * | 2013-06-19 | 2015-09-16 | 广州万孚生物技术股份有限公司 | 美沙酮半抗原及其制备方法、美沙酮抗原和美沙酮单克隆抗体及其应用 |
CN104558143B (zh) * | 2014-12-26 | 2018-01-05 | 杭州奥泰生物技术有限公司 | 一种eddp人工抗原的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5073629A (en) * | 1989-01-23 | 1991-12-17 | Abbott Laboratories | Methadone fluorescence polarization immunoassay |
CN2914089Y (zh) * | 2006-02-22 | 2007-06-20 | 万华普曼生物工程有限公司 | 快速检测美沙酮的胶体金试纸 |
CN102219709A (zh) * | 2011-05-06 | 2011-10-19 | 天津市中央药业有限公司 | 一种盐酸美沙酮中间体的合成方法 |
-
2012
- 2012-04-11 CN CN2012101056039A patent/CN102617730B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102617730A (zh) | 2012-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103360488A (zh) | 一种茶碱人工抗原的制备方法 | |
CN104402753B (zh) | 一种金刚烷胺人工半抗原、人工抗原及其制备方法和应用 | |
CN108017631B (zh) | 一种唑吡坦人工半抗原、人工抗原及其制备方法和应用 | |
CN101245032A (zh) | 隐孔雀石绿半抗原及制备得到的抗体和抗体的应用 | |
CN101962358A (zh) | 环丙沙星半抗原、人工抗原和抗体及其制备方法和应用 | |
CN102796102B (zh) | 咖啡因半抗原、偶联物及应用、咖啡因检测或测定方法 | |
CN102617730B (zh) | 一种美沙酮人工抗原的制备方法 | |
CN102250238A (zh) | 合成苦马豆素抗原的方法 | |
CN102627696B (zh) | 一种苯环利定人工抗原的制备方法 | |
CN103288952A (zh) | 一种去甲氯胺酮人工抗原的制备方法 | |
CN102336831A (zh) | 一种抗西地那非的特异性抗体 | |
CN112250641A (zh) | 双氢克尿噻半抗原、人工抗原、抗体及其制备方法和应用 | |
CN104558140A (zh) | 一种氯胺酮人工抗原的制备方法 | |
CN105968184A (zh) | 一种氯胺酮人工抗原的制备方法 | |
WO2013147586A1 (en) | A method for preparing an immunogen and a use thereof | |
CN110981875A (zh) | 一种阿托品半抗原及其合成方法、抗原、抗体和应用 | |
CN103804491B (zh) | 1,5-脱水山梨醇免疫原及其特异性抗体及检测试剂 | |
CN115991674A (zh) | 一种阿立哌唑人工半抗原、人工抗原及其制备方法和应用 | |
CN103360487A (zh) | 一种丙氧酚人工抗原的制备方法 | |
CN112608310B (zh) | 一种利培酮和9-羟基利培酮半抗原、抗原和抗体以及其应用 | |
CN109438424A (zh) | 利巴韦林半抗原和人工抗原及其制备方法与应用 | |
CN114014774A (zh) | 一种氟胺酮人工半抗原、人工抗原及其制备方法和应用 | |
CN106046143A (zh) | 一种苯胺绿人工抗原的制备方法 | |
CN104558143B (zh) | 一种eddp人工抗原的制备方法 | |
CN103524362A (zh) | 孔雀石绿人工抗原和抗体及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 310018, Zhejiang Hangzhou economic and Technological Development Zone, Poplar Street, Yinhai street, 550, workshop 2, third, fourth storey factory building Patentee after: HANGZHOU ALLTEST BIOTECH CO.,LTD. Address before: 1, No. 452, No. 6, No. 310018, Hangzhou economic and Technological Development Zone, Zhejiang, Hangzhou, 5A19 Patentee before: Hangzhou Peile Biological Technology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 310018, Zhejiang Hangzhou economic and Technological Development Zone, Poplar Street, Yinhai street, 550, workshop 2, third, fourth storey factory building Patentee after: HANGZHOU ALLTEST BIOTECH Co.,Ltd. Address before: 310018, Zhejiang Hangzhou economic and Technological Development Zone, Poplar Street, Yinhai street, 550, workshop 2, third, fourth storey factory building Patentee before: HANGZHOU ALLTEST BIOTECH CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 311215 workshop No. 550, workshop No. 550, Yinhai street, Baiyang street, Hangzhou economic and Technological Development Zone, Zhejiang Province, 2 and third, fourth floors Patentee after: HANGZHOU ALLTEST BIOTECH Co.,Ltd. Address before: 310018, Zhejiang Hangzhou economic and Technological Development Zone, Poplar Street, Yinhai street, 550, workshop 2, third, fourth storey factory building Patentee before: HANGZHOU ALLTEST BIOTECH Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 311215 Building 5, building 4, building 3, No. 550, Yinhai street, Baiyang street, Hangzhou Economic and Technological Development Zone, Hangzhou City, Zhejiang Province Patentee after: HANGZHOU ALLTEST BIOTECH Co.,Ltd. Address before: 311215 workshop No. 550, workshop No. 550, Yinhai street, Baiyang street, Hangzhou economic and Technological Development Zone, Zhejiang Province, 2 and third, fourth floors Patentee before: HANGZHOU ALLTEST BIOTECH Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |